GDF-15 treatment significantly reduced levels of IL-1β, IL-2, IL-4, IL-21, and IL-22 (Figures 6A–E), by which treatment of lupus mice with 100 μg/kg GDF-15 had the most efficiency. Here, GDF15 is linked to systemic lupus erythematosus.